Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acquired peripheral neuropathy

C H Chalk1

  • 1Montréal General Hospital, Montréal, Québec, Canada.

Neurologic Clinics
|August 1, 1997
PubMed
Summary

This review simplifies diagnosing chronic polyneuropathy by exploring acquired causes beyond diabetes. It covers metabolic, toxic, infectious, and immune-mediated conditions, highlighting new therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials.

Journal of the neurological sciences·2001
Same author

Diagnostic accuracy and certainty from sequential evaluations in peripheral neuropathy.

Neurology·2001
Same author

Classification of teased nerve fibers for multicenter clinical trials.

Journal of the peripheral nervous system : JPNS·2000
Same author

Role of the blink reflex in the evaluation of sensory neuronopathy.

Neurology·1999
Same author

Seronegativity for type 1 antineuronal nuclear antibodies ('anti-Hu') in subacute sensory neuronopathy patients without cancer.

Neurology·1993
Same author

Anti-neutrophil cytoplasmic antibodies in vasculitis peripheral neuropathy.

Neurology·1993

Area of Science:

  • Neurology
  • Internal Medicine

Background:

  • Polyneuropathy is a common neurological disorder with diverse etiologies.
  • Diabetic and acute-onset neuropathies are well-characterized, but acquired chronic forms require systematic evaluation.

Purpose of the Study:

  • To provide a diagnostic framework for acquired chronic polyneuropathies excluding diabetic and acute presentations.
  • To review the main categories of acquired polyneuropathies and recent therapeutic advancements.

Main Methods:

  • Literature review of acquired polyneuropathies.
  • Categorization of causes into metabolic, toxic/deficiency, infectious, and immune-mediated.
  • Inclusion of case histories to illustrate diagnostic and therapeutic approaches.

Main Results:

  • Established a simplified diagnostic approach for chronic polyneuropathy.
  • Detailed the key acquired causes, including metabolic disorders, toxic/deficiency states, infections, and immune-mediated conditions.
  • Summarized recent therapeutic progress for these polyneuropathies.

Conclusions:

  • A systematic approach aids in diagnosing various acquired chronic polyneuropathies.
  • Understanding these diverse causes is crucial for effective patient management.
  • Advances in therapy offer improved outcomes for patients with acquired polyneuropathies.

Related Experiment Videos